The common shares of Spackman Equities Group trades on the TSX Venture Exchange under the symbol SQG. Visit www.spackmanequities.com for further information.

Roche’s PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody test becomes the only FDA approved companion diagnostic indicated to aid assessment of HER2 low-metastatic breast cancer ...

HER2-Selective Tyrosine Kinase Inhibitor, Zongertinib (BI 1810631), in Patients With Advanced/Metastatic Solid Tumors With HER2 Alterations: A Phase Ia Dose-Escalation Study The article by Mascarenhas ...

Seagen is a specialist in antibody-drug conjugates, but has looked to Chinese biotech RemeGen for a HER2-targeting candidate that could challenge rival drugs from AstraZeneca/Daiichi Sankyo and Roche.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

After hours: March 3 at 6:22:24 PM EST Loading Chart for NEU ...

Biopharmaceutical company developing drugs for neurological disorders.

According to the staining intensity, the pathologist categorized HER-2 status as positive (IHC score = 3+), negative (IHC score = 0, 1+) or equivocal (inconclusive IHC score = 2+). Estrogen receptor ...

Tissue-resident macrophages (TRMs) are heterogeneous populations originating either from monocytes or embryonic progenitors, and distribute in lymphoid and non-lymphoid tissues. TRMs play diverse ...

From Cham Cham in Baaghi and Illegal Weapon 2.0 in Street Dancer to the latest Aayi Nahi in Stree 2, on Shraddha Kapoor's birthday, here are the top 5 songs of the actress ...